anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

226,621-226,680 of 319,975

filter-aware
10
Includes a patient-derived xenograft (PDX) study methodology diagram and a line chart showing tumor volume over time.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
11
The slide presents three separate line charts showing tumor growth inhibition over time for different cell lines (RL95-2, KLE, SNG-M).Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
12
The slide uses a patient selection strategy based on ARID1a mutation status.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
13
The slide uses a split-column layout to contrast two phases of a clinical trial.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
14
Nuvectis Pharma | Investor Presentation Deck | 25 slidesNuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · ProblemLoop · Voice Of Customer1 hit
15
Nuvectis Pharma | Investor Presentation Deck | 25 slidesNuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Voice Of Customer1 hit
16
The charts are kinome dendrograms (KinomeScan style).Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Voice Of Customer1 hit
17
The slide uses a structural biology mechanism of action (MOA) comparison to demonstrate competitive advantage.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Voice Of Customer1 hit
18
Includes a biological pathway diagram and an IC50 dose-response curve.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Loop · Voice Of Customer1 hit
19
Data shows tumor regression in treated groups vs growth in control groups over 27 days.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · TractionLoop · Voice Of Customer1 hit
20
Includes two distinct experimental setups: in vitro proliferation assays and in vivo bioluminescence imaging (BLI) tumor growth studies.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · TractionLoop · Voice Of Customer1 hit
21
The table segments indications by Squamous cell prevalence and NF2 mutation prevalence.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · TractionLoop · Voice Of Customer1 hit
22
Clinical trial identifier NCT05873686 is provided.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · Traction1 hit
23
Nuvectis Pharma | Investor Presentation Deck | 25 slidesNuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations 1 hit
24
The slide uses a chevron-based list layout to categorize key highlights.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations 1 hit
25
Nuvectis Pharma | Investor Presentation Deck | 25 slidesNuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations 1 hit
01
Slide 1
Features brand-specific illustration style depicting patient care and digital health services.Oscar Health | Investor Conference Presentation Deck | 9 slides · Oscar Health
Conference presentation Investor relations Beat · Humble Origins1 hit
02
Oscar Health | Investor Conference Presentation Deck | 9 slidesOscar Health | Investor Conference Presentation Deck | 9 slides · Oscar Health
Conference presentation Investor relations Beat · Humble Origins1 hit
03
Oscar Health | Investor Conference Presentation Deck | 9 slidesOscar Health | Investor Conference Presentation Deck | 9 slides · Oscar Health
Conference presentation Investor relations Beat · Humble Origins1 hit
04
The slide uses a hub-and-spoke style diagram to show the central brand 'Oscar' connecting to two distinct business lines.Oscar Health | Investor Conference Presentation Deck | 9 slides · Oscar Health
Conference presentation Investor relations Beat · Rising SuccessLoop · Quick Win Big Bet1 hit
05
The slide uses a dual-flywheel framework to represent the integration between member engagement and provider collaboration.Oscar Health | Investor Conference Presentation Deck | 9 slides · Oscar Health
Conference presentation Investor relations Beat · Rising SuccessLoop · Quick Win Big Bet1 hit
06
Includes a disclaimer regarding the calculation of Adjusted EBITDA.Oscar Health | Investor Conference Presentation Deck | 9 slides · Oscar Health
Conference presentation Investor relations Beat · Rising SuccessLoop · Quick Win Big Bet1 hit
07
Oscar Health | Investor Conference Presentation Deck | 9 slidesOscar Health | Investor Conference Presentation Deck | 9 slides · Oscar Health
Conference presentation Investor relations Beat · Ultimate AchievementLoop · Quick Win Big Bet1 hit
08
Oscar Health | Investor Conference Presentation Deck | 9 slidesOscar Health | Investor Conference Presentation Deck | 9 slides · Oscar Health
Conference presentation Investor relations Beat · Ultimate AchievementLoop · Quick Win Big Bet1 hit
09
Oscar Health | Investor Conference Presentation Deck | 9 slidesOscar Health | Investor Conference Presentation Deck | 9 slides · Oscar Health
Conference presentation Investor relations Beat · Ultimate AchievementLoop · Quick Win Big Bet1 hit
01
Slide 1
P3 Health Partners | Investor Conference Presentation Deck | 19 slidesP3 Health Partners | Investor Conference Presentation Deck | 19 slides · P3 Health Partners
Conference presentation Investor relations 1 hit
02
P3 Health Partners | Investor Conference Presentation Deck | 19 slidesP3 Health Partners | Investor Conference Presentation Deck | 19 slides · P3 Health Partners
Conference presentation Investor relations 1 hit
03
P3 Health Partners | Investor Conference Presentation Deck | 19 slidesP3 Health Partners | Investor Conference Presentation Deck | 19 slides · P3 Health Partners
Conference presentation Investor relations 1 hit
04
P3 Health Partners | Investor Conference Presentation Deck | 19 slidesP3 Health Partners | Investor Conference Presentation Deck | 19 slides · P3 Health Partners
Conference presentation Investor relations 1 hit
05
P3 Health Partners | Investor Conference Presentation Deck | 19 slidesP3 Health Partners | Investor Conference Presentation Deck | 19 slides · P3 Health Partners
Conference presentation Investor relations 1 hit
06
Includes a map of US operations and two waterfall-style growth charts for membership and revenue.P3 Health Partners | Investor Conference Presentation Deck | 19 slides · P3 Health Partners
Conference presentation Investor relations Beat · Problem1 hit
07
P3 Health Partners | Investor Conference Presentation Deck | 19 slidesP3 Health Partners | Investor Conference Presentation Deck | 19 slides · P3 Health Partners
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
08
PMPM stands for Per Member Per Month.P3 Health Partners | Investor Conference Presentation Deck | 19 slides · P3 Health Partners
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
09
The chart shows a clear downward trend in medical costs for all cohorts compared to the rising benchmark.P3 Health Partners | Investor Conference Presentation Deck | 19 slides · P3 Health Partners
Conference presentation Investor relations Beat · Market SizeLoop · Cost Of Inaction1 hit
10
The chart uses dashed lines with markers for three distinct metrics. A callout box provides the key takeaway comparing internal performance to industry trends.P3 Health Partners | Investor Conference Presentation Deck | 19 slides · P3 Health Partners
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
11
Includes IBNR for YTD Q3'23; excludes ACO Reach; represents MA only.P3 Health Partners | Investor Conference Presentation Deck | 19 slides · P3 Health Partners
Conference presentation Investor relations Loop · Hypothesis Test1 hit
12
P3 Health Partners | Investor Conference Presentation Deck | 19 slidesP3 Health Partners | Investor Conference Presentation Deck | 19 slides · P3 Health Partners
Conference presentation Investor relations Loop · Hypothesis Test1 hit
13
The slide uses a circular process diagram to represent the platform's core functions.P3 Health Partners | Investor Conference Presentation Deck | 19 slides · P3 Health Partners
Conference presentation Investor relations Beat · Solution1 hit
14
P3 Health Partners | Investor Conference Presentation Deck | 19 slidesP3 Health Partners | Investor Conference Presentation Deck | 19 slides · P3 Health Partners
Conference presentation Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
15
P3 Health Partners | Investor Conference Presentation Deck | 19 slidesP3 Health Partners | Investor Conference Presentation Deck | 19 slides · P3 Health Partners
Conference presentation Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
16
The chart shows a bridge from $(128)M in 2022 to $30M in 2024G.P3 Health Partners | Investor Conference Presentation Deck | 19 slides · P3 Health Partners
Conference presentation Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
17
P3 Health Partners | Investor Conference Presentation Deck | 19 slidesP3 Health Partners | Investor Conference Presentation Deck | 19 slides · P3 Health Partners
Conference presentation Investor relations 1 hit
18
The table includes adjustments for non-cash items like goodwill impairment and stock-based compensation.P3 Health Partners | Investor Conference Presentation Deck | 19 slides · P3 Health Partners
Conference presentation Investor relations 1 hit
19
P3 slide 18P3 Health Partners | Investor Conference Presentation Deck | 19 slides · P3 Health Partners
Conference presentation Investor relations 1 hit
01
Slide 1
Pathward Financial | Results Presentation Deck | 34 slidesPathward Financial | Results Presentation Deck | 34 slides · Pathward Financial
Conference presentation Investor relations 1 hit
02
Pathward Financial | Results Presentation Deck | 34 slidesPathward Financial | Results Presentation Deck | 34 slides · Pathward Financial
Conference presentation Investor relations 1 hit
03
Pathward Financial | Results Presentation Deck | 34 slidesPathward Financial | Results Presentation Deck | 34 slides · Pathward Financial
Conference presentation Investor relations Beat · ProblemLoop · Golden Circle1 hit
04
Pathward Financial | Results Presentation Deck | 34 slidesPathward Financial | Results Presentation Deck | 34 slides · Pathward Financial
Conference presentation Investor relations Beat · ProblemLoop · Golden Circle1 hit
05
Pathward Financial | Results Presentation Deck | 34 slidesPathward Financial | Results Presentation Deck | 34 slides · Pathward Financial
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
06
The slide uses a consistent color scheme (light blue for Q1 2023, dark blue for Q1 2024) and percentage change callouts for each metric.Pathward Financial | Results Presentation Deck | 34 slides · Pathward Financial
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
07
The slide highlights that total deposits remained flat (0% change) year-over-year.Pathward Financial | Results Presentation Deck | 34 slides · Pathward Financial
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
08
The slide uses a waterfall-style bridge to show growth between two periods.Pathward Financial | Results Presentation Deck | 34 slides · Pathward Financial
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
09
The donut chart shows total liquidity of $3.807B. The bar chart shows Q1 2024 share repurchases of 232,588 shares.Pathward Financial | Results Presentation Deck | 34 slides · Pathward Financial
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
10
The slide uses a numbered list format to present financial assumptions.Pathward Financial | Results Presentation Deck | 34 slides · Pathward Financial
Conference presentation Investor relations Beat · FinancialsLoop · Golden Circle1 hit
11
Pathward Financial | Results Presentation Deck | 34 slidesPathward Financial | Results Presentation Deck | 34 slides · Pathward Financial
Conference presentation Investor relations Beat · FinancialsLoop · Golden Circle1 hit
12
Pathward Financial | Results Presentation Deck | 34 slidesPathward Financial | Results Presentation Deck | 34 slides · Pathward Financial
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
13
Pathward Financial | Results Presentation Deck | 34 slidesPathward Financial | Results Presentation Deck | 34 slides · Pathward Financial
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
14
Includes adjustments for one-time items and 1st quarter earnings breakdowns.Pathward Financial | Results Presentation Deck | 34 slides · Pathward Financial
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
15
Includes a disclaimer note regarding share repurchases.Pathward Financial | Results Presentation Deck | 34 slides · Pathward Financial
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
16
Pathward Financial | Results Presentation Deck | 34 slidesPathward Financial | Results Presentation Deck | 34 slides · Pathward Financial
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit